Markets:

Overview

News

Currencies

International

Treasuries

Ascentage Pharma Group International - American Depository Shares (NQ:AAPG)

18.99 +0.43 (+2.32%)

Streaming Delayed Price Updated: 3:59 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ascentage Pharma Group International - American Depository Shares

This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 10, 2025

Via Benzinga

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗

November 05, 2025

Via Benzinga

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗

August 25, 2025

Via Benzinga

Earnings Scheduled For August 20, 2025 ↗

August 20, 2025

Via Benzinga

US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns' ↗

July 08, 2025

U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benchmark indices were trading mixed.

Via Benzinga

Topics Artificial Intelligence Government

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday ↗

July 08, 2025

Via Benzinga

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio? ↗

April 27, 2025

Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.

Via Benzinga

Topics Artificial Intelligence

Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday ↗

March 28, 2025

Via Benzinga

Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan ↗

March 27, 2025

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% YoY, driven by a Takeda payment.

Via Benzinga

IPO Momentum Builds In 2025: Diginex, CTRL Group, And Others Post Strong Gains ↗

March 10, 2025

US IPO activity saw a meaningful recovery in 2024, with 38% more IPOs and 48% higher proceeds. 2025 may bring even more growth as 36 IPOs have already been priced this year, including Diginex's 600%...

Via Benzinga

Topics Initial Public Offering

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.